Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Collider bias can distort our understanding of COVID-19 risk and severity.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Water near Abakaliki mines has high toxic metal levels, posing health risks.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Toxic Shock Syndrome mainly affects menstruating women, can recur, and is linked to staph bacteria, with rapid treatment being crucial.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Current treatments for alopecia show no significant long-term benefits.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

Masculine facial features may not reliably indicate heritable health, and more research is needed.

Eating disorders like anorexia and bulimia cause skin problems, and dermatologists can help detect these disorders early for better treatment outcomes.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

The conclusion is that the risk of losing significance in meta-analysis results increases with smaller effects and more missing data, and using the median standard deviation for imputation is recommended.

Testosterone's muscle-building effects do not require its conversion to DHT.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.